Topical antimicrobials in the management of chronic rhinosinusitis: A systematic review

被引:87
作者
Lim, Mingyann
Citardi, Martin J. [2 ]
Leong, Jern-Lin [1 ]
机构
[1] Singapore Gen Hosp, Dept Otolaryngol, Singapore 169608, Singapore
[2] Cleveland Clin Fdn, Head & Neck Inst, Cleveland, OH 44195 USA
来源
AMERICAN JOURNAL OF RHINOLOGY | 2008年 / 22卷 / 04期
关键词
antibiotics; antifungal; antimicrobials; culture-directed; irrigation; nasal; nebulizer; rhinosinusitis; spray; topical;
D O I
10.2500/ajr.2008.22.3189
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Chronic rhinosinusitis (CRS) is a common disease that can significantly impact health. The mainstay of medical treatment is topical steroids and oral antibiotics, but little is known about the efficacy of topical antibiotics. The purpose of this study was to identify evidence for the use of topical antibiotics in the treatment of CRS and exacerbations of CRS. Methods: Systematic review of literature with a search of the MEDLINE, EMBASE, and CINAHL databases; Cochrane Central Register of Controlled Trials (Third Quarter 2007); and Cochrane Database of Systemic Reviews (3rd Quarter 2007) databases were performed. The dates of search were from December 1, 1949 to September 30, 2007, Results: Fourteen studies that fulfilled the inclusion criteria were identified: seven were controlled trials and of these, five were double blinded and randomized. Only one of the randomized studies showed a positive outcome. Overall, there was low-level corroborative evidence for the use of antibacterials. No definite conclusions could be made regarding the use of antifungals. Currently, there is evidence for the use Of nasal irrigation or nebulization rather than delivery by nasal spray. For the antibacterial studies, the highest level of evidence currently exists for studies that have used postsurgical patients and culture-directed therapy. Both stable and acute exacerbations of CRS appear to benefit from topical antimicrobials. Conclusion: Topical antibiotics appear effective in the management of CRS. Given the combination of low-level evidence (level III, with inherent potential confounders of natural progression of disease and placebo effect) and the level IIb evidence being limited to the cystic fibrosis group of patients, topical antibiotics should not be first-line management but may be attempted in patients refractory to the traditional topical steroids and oral antibiotics. Larger and better-designed randomized double-blind placebo-con trolled trials are required to more fully evaluate this emerging modality of treatment.
引用
收藏
页码:381 / 389
页数:9
相关论文
共 39 条
  • [1] The economic burden and symptom manifestations of chronic rhinosinusitis
    Bhattacharyya, N
    [J]. AMERICAN JOURNAL OF RHINOLOGY, 2003, 17 (01): : 27 - 32
  • [2] Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro
    Desrosiers, Martin
    Bendouah, Zohra
    Barbeau, Jean
    [J]. AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (02): : 149 - 153
  • [3] Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: Results of a controlled trial
    Desrosiers, MY
    Salas-Prato, M
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 125 (03) : 265 - 269
  • [4] Penetration of cefuroxime into chronically inflamed sinus mucosa
    Dinis, PB
    Monteiro, MC
    Lobato, R
    Martins, ML
    Gomes, A
    [J]. LARYNGOSCOPE, 1999, 109 (11) : 1841 - 1847
  • [5] Preliminary study of the deposition of aerosol in the maxillary sinuses using a plastinated model
    Durand, M
    Rusch, P
    Granjon, D
    Chantrel, G
    Prades, JM
    Dubois, F
    Esteve, D
    Pouget, JF
    Martin, C
    [J]. JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (01): : 83 - 93
  • [6] Amphotericin B nasal lavages: Not a solution for patients with chronic rhinosinusitis
    Ebbens, Fenna A.
    Scadding, Glenis K.
    Badia, Lydia
    Hellings, Peter W.
    Jorissen, Mark
    Mullol, Joaquim
    Cardesin, Alda
    Bachert, Claus
    van Zele, Thibaut P. J.
    Dijkgraaf, Marcel G. W.
    Lund, Valerie
    Fokkens, Wytske J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (05) : 1149 - 1156
  • [7] Elliott KA, 2006, AM J RHINOL, V20, P1
  • [8] FAIRBANKS DNF, 1993, OTOLARYNG CLIN N AM, V26, P549
  • [9] Fokkens W., 2007, RHINOLOGY, V45, P1
  • [10] STUDY OF THE EFFICACY AND SAFETY OF CIPROFLOXACIN IN THE TREATMENT OF CHRONIC SINUSITIS
    FOMBEUR, JP
    BARRAULT, S
    KOUBBI, G
    LAURIER, JN
    EBBO, D
    LECOMTE, F
    SORREL, N
    DOBLER, S
    [J]. CHEMOTHERAPY, 1994, 40 : 24 - 28